Ethamolin 5% ampul 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5RF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,178
Award facts
- Contract value 100% obligated
- $10,177.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 27, 2026, the Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of Ethamolin 5% Ampul 2ML, a sclerosing agent used in medical treatment. This firm fixed-price delivery order, valued at $10,177.56, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by January 28, 2026. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen Drug Corp's role as a child entity of Cencora, Inc. (formerly known as Amerisourcebergen), which serves as the prime contractor for the DLA's pharmaceutical supply operations.
This delivery order leverages Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses an extensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains. The non-set-aside award reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition and underscores the critical role pharmaceutical distributors play in sustaining military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FT5RF?
SPE2DR26FT5RF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FT5RF worth?
The government has obligated $10,178 on SPE2DR26FT5RF.
Is contract SPE2DR26FT5RF an order under another contract?
Yes. SPE2DR26FT5RF is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5RF competed?
The extent of competition for SPE2DR26FT5RF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award